The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | A | Alimentary tract and metabolism | |
2 | A11 | Vitamins | |
3 | A11C | Vitamin A and D, incl. combinations of the two | |
4 | A11CC | Vitamin D and analogues |
Code | Title | |
---|---|---|
A11CC01 | Ergocalciferol | |
A11CC02 | Dihydrotachysterol | |
A11CC03 | Alfacalcidol | |
A11CC04 | Calcitriol | |
A11CC05 | Colecalciferol | |
A11CC06 | Calcifediol | |
A11CC08 | Doxercalciferol | |
A11CC20 | Combinations |
Active Ingredient | Description | |
---|---|---|
Alfacalcidol |
Alfacalcidol is Vitamin D-hormone analog (an active metabolite of Vitamin D), which performs important functions in regulation of the calcium balance and the bone metabolism and is activated by the enzyme 25-hydroxylase (converted rapidly in the liver to 1,25-dihydroxyvitamin D) for systemic and in osteoblasts for local D-hormone actions. |
|
Calcidiol |
Vitamin D3 must undergo a two-step metabolic process to be active; the first step occurs in the microsomal fraction of the liver where Vitamin D is hydroxylated at position 25 (25-hydroxycholecalciferol or calcifediol); the second step takes place in the kidney where 1,25-dihydroxycholecalciferol or calcitriol is formed due to the activity of enzyme 25-hydroxycholecalciferol 1-hydroxylase. Vitamin D increases absorption of calcium and phosphorus in the intestine and improves normal bone formation and mineralization. |
|
Calcitriol |
Calcitriol is the most active known form of vitamin D3 in stimulating intestinal calcium transport. In physiological amounts it augments the intestinal absorption of calcium and phosphate and plays a significant part in the regulation of bone mineralisation. |
|
Doxercalciferol |
Doxercalciferol is a synthetic vitamin D2 analog that requires metabolic activation to form the active 1α,25-(OH)2D2 metabolite, which binds to the vitamin D receptor (VDR) to result in the selective activation of vitamin D responsive pathways. Vitamin D and doxercalciferol have been shown to reduce PTH levels by inhibiting PTH synthesis and secretion. |
|
Falecalcitriol |
|
|
Maxacalcitol |
|
|
Vitamin D2 |
Vitamin D2 (ergocalciferol) is a fat soluble vitamin. In conjunction with parathyroid hormone and calcitonin, it regulates calcium haemostasis. Ergocalciferol metabolites promote active absorption of calcium and phosphorous by the small intestine, increase rate of excretion and resorption of minerals in bone and promote resorption of minerals in bone and promote resorption of phosphate by renal tubules. |
|
Vitamin D3 |
In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated. |
Title | Information Source | Document Type | |
---|---|---|---|
DESUNIN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
FULTIUM-D3 Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ONE-ALPHA Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ONE-ALPHA Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ROCALTROL Soft capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
STRIVIT-D3 800 IU Capsule, soft | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
THORENS Capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZODORAY Capsule | Health Products Regulatory Authority (ZA) | MPI, Generic |